DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT

Information source: Pfizer
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Intervention: Eplerenone (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Pfizer

Official(s) and/or principal investigator(s):
Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer

Summary

To investigate the impact of antihypertensive therapy with the selective mineralocorticoid receptor blocker, eplerenone, on small resistance artery remodeling, compared to the effect of equivalent blood pressure control achieved with a b-blocker, atenolol.

Clinical Details

Official title: A Double-Blind, Parallel Design Study to Compare the Effectiveness of Eplerenone Versus Atenolol in Reversing the Remodeling of Resistance Arteries in Subjects With Mild to Moderate Primary Hypertension

Study design: Treatment, Non-Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study

Primary outcome: The change from baseline to week 52 in the media/lumen ratio and the maximum % relaxation response to acetylcholine of gluteal subcutaneous resistance vessels, measured from the gluteal biopsy.

Secondary outcome: Will be done for both the Intent to Treat and per protocol populations, and use both the LOCF and OC methods

Eligibility

Minimum age: 30 Years. Maximum age: 70 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Pt with essential hypertension who have never been treated or untreated within the

previous 6 months

Exclusion Criteria:

- History of Malignant Hypertension

- Sitting diastolic blood pressure > 115mmHg or sitting Systolic blood pressure >

200mmHg

Locations and Contacts

Pfizer Investigational Site, Montreal, Quebec H2W 1R7, Canada
Additional Information

To obtain contact information for a study center near you, click here.

Link to ClinicalStudyResults.org Posting:

Starting date: October 2003
Ending date: May 2006
Last updated: April 14, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009